It is estimated that China will experience almost $2 trillion in new consumer-driven consumption by 2021, and Chinese consumers are about twice as likely to use a mobile device to make retail purchases as consumers in Europe and the United States. Right in line to capitalize on this, Moxian, Inc. (NASDAQ: MOXC) has recently upgraded…
Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO), a leader in the development and sale of innovative solutions for the worldwide life sciences industry, this morning announced a collaboration with Phasex Corporation, one of the world’s most experienced supercritical fluid (“SCF”)-based toll processors. The goal of the collaboration is to combine PBI’s recently patented Ultra Shear Technology with…
India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning provided compelling in vitro data compiled from genetically engineered cell lines within an Alzheimer’s disease model showing that, at varying concentrations of IGC-AD1, the expression of GSK3β is reduced by as much as 62…
India Globalization Capital (NYSE MKT: IGC), a first mover in the cannabis-based combination therapy space, recently announced that it is readying a line of cannabis-based medical dispensary products that target Alzheimer’s disease (http://dtn.fm/tQo00). IGC is engineering genetic cell lines which demonstrate that, at various concentrations of tetrahydrocannabinol (THC), the protein Aβ decreases as much as…
Licensed Canadian cannabis cultivation company Emblem Corp. (TSX.V: EMC) (OTC: EMMBF) recently entered into a collaboration and licensing agreement with Canntab Therapeutics Limited to collaborate on the preclinical formulation, clinical development, regulatory approval, manufacturing and commercialization of Canntab’s patent-pending oral sustained release cannabinoid formulation. The agreement grants Emblem the exclusive right to Canntab’s patents and…
Canadian energy exploration and development company Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) this morning offered an update on its exploration and process testing program at its Bristol Dry Lake lithium brine projected located in California’s Mojave Desert. Per the release, the company has commenced a resource definition drill program on the project…
Global financial technology and value-added solutions group Net Element, Inc. (NASDAQ: NETE) this morning announced that its Aptito subsidiary will exhibit at the 2017 Florida Restaurant & Lodging Show scheduled to take place from October 11-13 at the Orange County Convention Center in Orlando, Florida. The event is expected to provide Aptito with added exposure…
India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning provided an update on compelling in vitro data compiled from genetically engineered cell lines within an Alzheimer’s disease model showing that, at varying concentrations of IGC-AD1, mitochondrial function is enhanced by 30-60 percent. “Based…
Within the global market, consumer trends are ever tending toward the utilization of mobile devices when making purchases and otherwise connecting with businesses—something seen particularly among Chinese consumers. Well aware of China’s cashless trend, Moxian, Inc. (NASDAQ: MOXC) is cashing in by serving the online-to-offline (O2O) market with its Moxian User App and Business App—both…
In response to compelling recent data, India Globalization Capital, Inc. (NYSE MKT: IGC) announced it has made a highly significant novel breakthrough in treating Alzheimer’s disease with tetrahydrocannabinol (THC)—an advancement that could potentially bring much-needed relief to Alzheimer’s sufferers. A recent IGC press release (http://dtn.fm/c94Va) gave an update on in vitro data that has been…
A recent Global Mobile Money Report by Nielsen (http://dtn.fm/7rflL) shows that almost half of Chinese consumers will likely use a mobile device to make payments in restaurants, bars and retail stores—a much higher number than among consumers in the United States and Europe. Cashing in on China’s cashless trend and having recently upgraded its mobile…
Travel and technology company Monaker Group, Inc. (OTCQB: MKGI) this morning announced that it has been invited to present at the Third Annual Robins Equity Research Roundup, which is scheduled to take place September 26-27 at the Shilo Inn and Suites in Portland, Oregon. Monaker CEO Bill Kerby is scheduled to present on Tuesday, September…
India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning provided an update on compelling in vitro data compiled from genetically engineered cell lines within an Alzheimer’s disease model. Per the update, the aggregation of Aβ protein in the cerebral cortex and hippocampus, which…
In an effort to expand more rapidly in China, Moxian, Inc. (NASDAQ: MOXC) has shifted the focus of its joint venture strategy, including the agreement with Shewn International Group of Shanghai. An excerpt of an article further discussing this topic reads: “Moxian, Inc. has changed its business strategy to grow more quickly within China, targeting…
India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced compelling in vitro data compiled from genetically engineered cell lines showing that, at varying concentrations of THC, the production of Aβ40 protein decreases by as much as 50 percent over a 48-hour period.…
Travel and technology company Monaker Group, Inc. (OTCQB: MKGI) this morning announced that it has divested certain non-core assets for total consideration of $2.9 million. Additionally, the company has completed the conversion of $1.4 million of convertible debt owned by a long-term shareholder and company insider, eliminating the remainder of its convertible debt in preparation…
Alzheimer’s is the most expensive disease in the United States, and pharmaceutical companies are racing to find viable treatments for this devastating disease, which currently affects more than 5.3 million Americans and their loved ones. Wall Street is placing bets on who will win the race to treat Alzheimer’s, and India Globalization Capital (NYSE MKT:…
In January 2017, Crystal Equity Research LLC published an initial report on Moxian, Inc. (NASDAQ: MOXC) with a price target of $5.25, and that price target remains unchanged as of an August 15 updated report from Crystal. Crystal categorized investment in Moxian as a “speculative buy” and made positive note of the company’s joint venture…
The quickly growing e-commerce market in the United States provides plentiful opportunities for investment into online payment solution providers like Net Element, Inc. (NASDAQ: NETE) and its subsidiary PayOnline, a groundbreaking and flexible payment processing platform. As consumers benefit from an increasing number of channels for online ordering—driven by the marked preference of younger generations…
India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced its financial results for the quarter ended June 30, 2017. “During the quarter, we secured an IP licensing agreement from the University of South Florida addressing a potential treatment for Alzheimer’s disease,” Ram…